Howard W. Robin

2010

In 2010, Howard W. Robin earned a total compensation of $4.5M as President and Chief Executive Officer at Nektar Therapeutics, a 50% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$700,000
Option Awards$3,018,950
Salary$758,581
Other$14,973
Total$4,492,504

Robin received $3M in option awards, accounting for 67% of the total pay in 2010.

Robin also received $700K in non-equity incentive plan, $758.6K in salary and $15K in other compensation.

Rankings

In 2010, Howard W. Robin's compensation ranked 1,198th out of 10,439 executives tracked by ExecPay. In other words, Robin earned more than 88.5% of executives.

ClassificationRankingPercentile
All
1,198
out of 10,439
89th
Division
Manufacturing
441
out of 3,837
89th
Major group
Chemicals And Allied Products
95
out of 923
90th
Industry group
Drugs
55
out of 682
92nd
Industry
Pharmaceutical Preparations
47
out of 480
90th
Source: SEC filing on April 30, 2013.

Robin's colleagues

We found four more compensation records of executives who worked with Howard W. Robin at Nektar Therapeutics in 2010.

2010

Stephen Doberstein

Nektar Therapeutics

Chief Scientific Officer

2010

Rinko Ghosh

Nektar Therapeutics

Senior Vice President and Chief Business Officer

2010

John Nicholson

Nektar Therapeutics

Chief Financial Officer

2010

Gil Labrucherie

Nektar Therapeutics

General Counsel

News

In-depth

You may also like